NCT02421263View on ClinicalTrials.gov

The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 5, 2020

Study Completion Date

June 5, 2020

Conditions
Religious or Spiritual Problem
Interventions
DRUG

Psilocybin

Participants will receive 20 mg/70 kg of psilocybin in the first session and will receive either 20 or 30 mg/70 kg in the second session.

Trial Locations (1)

10016

NYU Langone Medical Center/Tisch Hospital, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02421263 - The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals | Biotech Hunter | Biotech Hunter